Italy's medicines agency lists drugs whose sales approval has lapsed
Italy's medicines agency AIFA has issued a formal determination, dated 30 October 2026 and published on 7 November 2026, that lists medicines whose marketing approval has lapsed. A marketing authorisation is the official permission to sell a medicine, and it lapses when the product is not actually sold within the set time. The notice is signed by Dr. Laura Braghiroli, who heads AIFA's post-authorisation procedures office.
This summary was generated by AI; the official source prevails.
What does it mean?
If a medicine is approved to sell in Italy but is never actually put on the market, its official permission can expire. This notice formally records the medicines whose permission has now expired for that reason. It is mainly relevant to pharmacies, drug makers, and anyone tracking which products are still legally available.
Who is affected?
Drug companies holding approvals for the listed medicines, and pharmacies and patients who rely on those products.